Franziska Ganster, Friederike Kallenberg, Anna Titova, Laura Hahn, Susanne Beyer, Maximilian Stocker, Maria Fischer, Mirjana Kessler, Sven Mahner, Thomas Kolben, Udo Jeschke, Sarah Meister
{"title":"Epigenetic alterations in the placenta associated with SARS-CoV-2 infection during pregnancy.","authors":"Franziska Ganster, Friederike Kallenberg, Anna Titova, Laura Hahn, Susanne Beyer, Maximilian Stocker, Maria Fischer, Mirjana Kessler, Sven Mahner, Thomas Kolben, Udo Jeschke, Sarah Meister","doi":"10.1007/s00404-026-08589-8","DOIUrl":"https://doi.org/10.1007/s00404-026-08589-8","url":null,"abstract":"<p><p>Histone modifications play a key role in chromatin organization and transcriptional regulatory potential. Previously, reduced levels of trimethylated histone H3K4me3 and acetylated H3K9ac were observed in placentas from women with preeclampsia. Building on these findings, this study investigated whether SARS-CoV-2 infection during pregnancy or at delivery is associated with changes in placental histone modifications. Immunohistochemical staining, exploratory western blot analysis, and qualitative immunofluorescence were performed on placental sections from 60 patients stratified into four groups: women with acute SARS-CoV-2 infection at delivery, women with prior infection during gestation, vaccinated controls, and unvaccinated controls. H3K4me3 levels in the syncytiotrophoblast were significantly reduced in both SARS-CoV-2-exposed groups compared to unvaccinated controls, with the most pronounced reduction observed in women with prior infection during gestation. H3K9ac levels did not differ significantly between groups in any compartment after correction for multiple comparisons. No significant associations were found between SCT H3K4me3 levels and maternal age, gestational age, or birthweight, and a sensitivity analysis excluding cases with additional placental pathologies confirmed the robustness of the findings. As no gene expression profiling was performed, functional or transcriptional consequences of the observed H3K4me3 changes cannot be inferred. These descriptive findings warrant further investigation integrating epigenetic and transcriptomic approaches to clarify their functional relevance for placental biology and pregnancy outcomes.</p>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria Eleni Hatzipanagiotou, Kathrin Hartwig, Miriam Fernandez-Pacheco, Sara Plavic-Radeka, Jonas Roth, Ivana Holzhauser, Simone Hammer, Olaf Ortmann, Stephan Seitz
{"title":"Patient acceptance and implementation of automated breast ultrasound in intensified breast cancer surveillance.","authors":"Maria Eleni Hatzipanagiotou, Kathrin Hartwig, Miriam Fernandez-Pacheco, Sara Plavic-Radeka, Jonas Roth, Ivana Holzhauser, Simone Hammer, Olaf Ortmann, Stephan Seitz","doi":"10.1007/s00404-026-08603-z","DOIUrl":"10.1007/s00404-026-08603-z","url":null,"abstract":"<p><strong>Purpose: </strong>Automated breast ultrasound (ABUS) is a standardized ultrasound technique that may reduce operator dependency compared with hand-held ultrasound. Evidence on patient acceptance and implementation in intensified breast cancer surveillance remains limited. This study evaluated patient acceptance and clinical implementation of ABUS within a certified center of the German Consortium for Hereditary Breast and Ovarian Cancer.</p><p><strong>Methods: </strong>In this prospective single-center observational study, women enrolled in an intensified breast cancer surveillance program underwent ABUS examinations and completed standardized questionnaires. Patient-reported outcomes included examination-related discomfort, comparison with mammography, willingness to repeat the examination, and willingness to recommend ABUS. Workflow parameters and changes in acquisition time over repeated examinations were assessed prospectively.</p><p><strong>Results: </strong>73 women contributed 162 ABUS examinations and corresponding questionnaires. Of these, 46/73 (63.0%) carried pathogenic variants in BRCA1, BRCA2, PALB2, or TP53, and 27/73 (37.0%) had a previous breast cancer diagnosis. Median pain score was 0 (IQR 0-1) for both breasts. Among women with previous mammography and an available comparative rating, 56/57 (98.2%) rated ABUS as more comfortable. All 73 participants (100%) were willing to undergo future ABUS examinations and recommend the procedure. Mean acquisition and interpretation times were 31.9 ± 6.2 and 9.95 ± 4.0 min, respectively. Acquisition time decreased significantly with increasing examination number (β = - 1.72 min/examination; p < 0.001).</p><p><strong>Conclusions: </strong>ABUS was associated with high reported patient acceptance and was feasible to integrate into intensified breast cancer surveillance, with improving acquisition efficiency over time.</p>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768209/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anita C Windhorst, Friederike S Tönnies, Aline Wolter, Frank Oehmke, Ivo Meinhold-Heerlein, Roland Axt-Fliedner
{"title":"Temporal influences in non-elective cesarean sections and indication patterns.","authors":"Anita C Windhorst, Friederike S Tönnies, Aline Wolter, Frank Oehmke, Ivo Meinhold-Heerlein, Roland Axt-Fliedner","doi":"10.1007/s00404-026-08604-y","DOIUrl":"https://doi.org/10.1007/s00404-026-08604-y","url":null,"abstract":"<p><strong>Purpose: </strong>Elective (pre-labour) cesarean sections are, by design, concentrated during staffed hours, limiting the interpretability of overall temporal patterns. We examined whether the proportion of documented discretion-susceptible indications for non-elective (intrapartum) cesarean sections shifts with time of day and weekday, using the Robson classification for stratification.</p><p><strong>Methods: </strong>We retrospectively analysed 5,850 cesarean sections at University Hospital Giessen and Marburg, 2015-2021, classified as elective (n=2,851) or non-elective (n=2,998) by documented decision timepoint. Among non-elective cases, we assessed threshold-susceptible (\"soft\") indications (protracted labour/arrest, non-reassuring fetal heart rate) by shift and weekend, adjusted for Robson group and gestational age. Guideline-defined absolute (\"hard\") indications served as a supportive comparison, with Holm correction for exploratory comparisons.</p><p><strong>Results: </strong>Among non-elective cesarean sections, the proportion with documented discretion-susceptible indications was significantly higher during evening/night shifts (OR 2.63, 95%CI 2.20-3.14, p<0.001) and, less markedly, on weekends (OR 1.37, 95%CI 1.12-1.67, p=0.002), consistent across all five individual indicators for shift, and across two of five for weekend. Indications with limited clinical discretion showed no comparable variation (shift OR 0.99, p=0.92; weekend OR 0.77, p=0.16), except for placenta previa (Holm-p=0.023), discussed as a qualification rather than a validation of the primary interpretation.</p><p><strong>Conclusion: </strong>The proportion of non-elective cesarean sections with documented discretion-susceptible indications was higher during evening/night shifts and weekends, while guideline-defined indications with limited discretion showed comparatively little variation. Because a population-based at-risk denominator was unavailable, these findings describe differences in documented indication composition among cesarean deliveries that occurred, rather than evidence that the intervention threshold itself changed. Whether this reflects clinical decision-making, documentation practice, or unmeasured case-mix factors warrants further investigation.</p>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jann Lennard Scharf, Michael Gembicki, Amrei Welp, Guido Stichtenoth, Verena Sailer, Jan Weichert
{"title":"Correction: Life-threatening fetal goiter: diagnosis and outcomes in four consecutive cases with critical appraisal—why this diagnosis is not obviously trivial","authors":"Jann Lennard Scharf, Michael Gembicki, Amrei Welp, Guido Stichtenoth, Verena Sailer, Jan Weichert","doi":"10.1007/s00404-026-08562-5","DOIUrl":"10.1007/s00404-026-08562-5","url":null,"abstract":"","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13724632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Schultz Annemarie, Peters Frederik, Jaeger Anna, Schmalfeldt Barbara
{"title":"Surgical quality and long-term outcomes in advanced ovarian cancer: a population based registry study from Hamburg, Germany 2014–2024","authors":"Schultz Annemarie, Peters Frederik, Jaeger Anna, Schmalfeldt Barbara","doi":"10.1007/s00404-026-08578-x","DOIUrl":"10.1007/s00404-026-08578-x","url":null,"abstract":"<div><h3>Purpose</h3><p>To evaluate the association of surgical quality and survival in patients with advanced ovarian cancer in a real-world setting.</p><h3>Methods</h3><p>This population-based registry study analysed FIGO stage III/IV ovarian cancer patients in Hamburg, Germany (2014–2024). Patients were categorized by surgical outcome (no macroscopic residuals vs. macroscopic residuals). Kaplan–Meier functions and Cox proportional hazards models estimated associations with survival outcomes.</p><h3>Results</h3><p>The cohort comprised 576 patients (median age 65 years, median follow-up 57 months). No macroscopic residuals were achieved in 370 patients (64.2%). In multivariable analysis, no macroscopic residuals were associated with reduced mortality risk (HR 0.62, 95% CI: 0.42–0.90) and reduced progression risk (HR 0.68, 95% CI: 0.49–0.94). Advanced FIGO stage, poor performance status, and increasing age were independent predictors of worse outcomes.</p><h3>Conclusion</h3><p>Achieving no macroscopic residuals remains a critical prognostic factor in advanced ovarian cancer. The rate of 64.2% demonstrates that optimal surgical outcomes are achievable in routine practice, though opportunities for improvement remain compared to specialized centres.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13719812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Point-of-care ultrasound in obstetrics and gynecology: latest advancements and evolution","authors":"Florian Recker","doi":"10.1007/s00404-026-08584-z","DOIUrl":"10.1007/s00404-026-08584-z","url":null,"abstract":"<div><p>Point-of-care ultrasound (POCUS) in obstetrics and gynecology has evolved from a pragmatic bedside adjunct into a rapidly expanding clinical, educational and technological field. Since the publication of earlier narrative reviews, the discipline has been reshaped by handheld ultrasound systems, wireless probes, cloud-based image management, tele-ultrasound, artificial intelligence (AI) for image acquisition and interpretation, and the first specific practice guidance for POCUS in obstetrics and gynecology. This narrative review summarizes recent advances and proposes a clinically useful framework for the European ultrasound community. POCUS should be understood as a focused, problem-oriented and immediately actionable ultrasound examination performed and interpreted by the treating clinician. It is not a replacement for guideline-based screening, detailed fetal anatomy assessment, comprehensive transvaginal gynecologic imaging, Doppler surveillance or expert ultrasound. The strongest evidence supports POCUS for early pregnancy triage, confirmation of fetal viability and presentation, basic assessment of placental location and amniotic fluid, intrapartum evaluation of fetal head position and selected postpartum or gynecologic emergencies. In gynecology, POCUS can accelerate triage of acute pelvic pain, suspected ectopic pregnancy, intrauterine device position and adnexal pathology, but definitive risk stratification of complex masses remains a task for standardized specialist sonography. Technological progress has been substantial: handheld devices now provide diagnostically useful images for several focused tasks, AI-enabled blind-sweep protocols can estimate gestational age and fetal malpresentation in low-resource settings, and tele-ultrasound can extend expert support beyond tertiary centers. The next phase of OB/GYN POCUS will depend less on device availability than on implementation: indication-specific protocols, formal training, competency assessment, documentation, image archiving, infection control, data protection, quality assurance and clear escalation rules. POCUS in obstetrics and gynecology should therefore be framed as a governed clinical pathway rather than a device-driven shortcut.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-026-08584-z.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149178868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hyaluronan-enriched transfer medium in routine clinical practice: a retrospective cohort study showing no improvement in pregnancy outcomes among predominantly frozen embryo transfer cycles","authors":"Pelin Coştur Filiz, Serdar Filiz","doi":"10.1007/s00404-026-08592-z","DOIUrl":"10.1007/s00404-026-08592-z","url":null,"abstract":"<div><h3>Purpose</h3><p>To evaluate the effect of hyaluronan-enriched transfer medium (HETM; EmbryoGlue) on clinical pregnancy rates in a predominantly frozen embryo transfer (FET) cohort and to identify independent predictors of outcome.</p><h3>Methods</h3><p>In this retrospective, nonrandomized cohort study, we analyzed 335 embryo transfer cycles at a university-based ART unit (June 2025–April 2026): HETM group (EmbryoGlue, <i>n</i> = 171) vs. control (Irvine NX medium, <i>n</i> = 164). Allocation to transfer medium was based on shared clinical decision-making. The primary outcome was clinical pregnancy rate per cycle. Multivariate logistic regression identified independent predictors.</p><h3>Results</h3><p>FET accounted for 87.5% of cycles. Overall clinical pregnancy rate was 56.7% (190/335). Rates were comparable between HETM and control groups (56.7% vs. 56.7%; OR = 1.00, 95% CI 0.65–1.54; <i>p</i> > 0.999). No statistically significant between-group differences were observed in exploratory subgroups, including women aged ≥ 35 years, cycles with two or more previous transfer attempts, and blastocyst transfers (all <i>p</i> > 0.05). Despite a higher proportion of cycles with two or more previous transfer attempts in the HETM group (41.5% vs. 27.4%; <i>p</i> = 0.008), HETM was not an independent predictor of pregnancy (OR = 0.89, 95% CI 0.55–1.46; <i>p</i> = 0.652). FET (OR = 4.32; <i>p</i> < 0.001), blastocyst-stage transfer (OR = 2.96; <i>p</i> < 0.001), and younger age (OR = 0.92 per year; <i>p</i> = 0.001) were independently associated with clinical pregnancy.</p><h3>Conclusions</h3><p>HETM use was not associated with higher clinical pregnancy rates in this cohort. Transfer type, embryo stage, and patient age were independently associated with clinical pregnancy. These findings do not provide evidence supporting the routine use of EmbryoGlue in unselected FET populations.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13714025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is the reported benefit of the Endo-App truly sustained?","authors":"Zahide Küçük","doi":"10.1007/s00404-026-08582-1","DOIUrl":"10.1007/s00404-026-08582-1","url":null,"abstract":"","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13633360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Niklas Amann, Kim Wagner, Philipp Ziegler, Annika Krückel, Lena Brückner, Julia Gocke, Carolin Müller, Christoph Runz, Felix Heindl, C. Carolin Hack, Julius Emons, A. Peter Fasching, W. Matthias Beckmann, Manuel Hörner
{"title":"Risk-reducing salpingo-oophorectomy in patients with gBRCA-mutated breast cancer","authors":"Niklas Amann, Kim Wagner, Philipp Ziegler, Annika Krückel, Lena Brückner, Julia Gocke, Carolin Müller, Christoph Runz, Felix Heindl, C. Carolin Hack, Julius Emons, A. Peter Fasching, W. Matthias Beckmann, Manuel Hörner","doi":"10.1007/s00404-026-08581-2","DOIUrl":"10.1007/s00404-026-08581-2","url":null,"abstract":"<div><h3>Purpose</h3><p>Breast cancer (BC) patients with pathogenic germline <i>BRCA1/2</i> mutations (<i>gBRCA1/2mut)</i> have a substantially increased risk of ovarian cancer (OC). Risk-reducing bilateral salpingo-oophorectomy (RRSO) remains the only effective preventive strategy. However, data on the utilization and time to RRSO in g<i>BRCA</i>mut BC patients are limited.</p><h3>Methods</h3><p>This retrospective study included 148 patients with <i>gBRCA1/2mut</i> BC treated at the Hereditary Breast and Ovarian Cancer Center, University Hospital Erlangen, between 2012 and 2024. Clinical, pathological, treatment-related, and genetic data were collected and analyzed from electronic records. Time to RRSO at date of BC surgery was calculated for all patients, and stratified according guideline recommendations for RRSO, using the Kaplan–Meier method.</p><h3>Results</h3><p>In this cohort of 148 patients with <i>gBRCAmut</i> BC, 60.8% harbored a <i>gBRCA1</i> and 39.2% a <i>gBRCA2</i> mutation. BC was diagnosed at the mean age of 47.1 years, 73.6% presenting at UICC stage I–II. 47.9% of patients presented with triple-negative BC, 38.4% of patients with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative BC and 8.9% with HER2-positive BC. 101 patients (68.2%) additionally underwent RRSOs. The 12-month RRSO-free probability was 0.58 (95% CI 0.50–0.68) and the 24-month RRSO-free probability 0.39 (95% CI 0.31–0.49). Occult OC was detected in three patients at the time of RRSO during BC follow-up, four patients without RRSO were diagnosed with OC after BC.</p><h3>Conclusions</h3><p>In real-world setting, RRSO is a common prevention in g<i>BRCA</i>mut BC follow-up. The majority of patients undergo surgery within the first two years following a BC diagnosis. Survival outcomes among patients with BC have improved substantially in recent years. Consequently, developing OC in g<i>BRCA</i>mut BC individuals still remains a risk. RRSO should therefore continue to be offered and discussed in accordance with current guidelines, even in the context of a BC diagnosis.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13619706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Isabel Hoffmann, Jochen Maurer, Christian Enzensberger, Elmar Stickeler, Oliver Graupner
{"title":"Expression patterns of circulating microRNA in confirmed early-onset and late-onset pre-eclampsia cases","authors":"Isabel Hoffmann, Jochen Maurer, Christian Enzensberger, Elmar Stickeler, Oliver Graupner","doi":"10.1007/s00404-026-08583-0","DOIUrl":"10.1007/s00404-026-08583-0","url":null,"abstract":"<div><h3>Purpose</h3><p>The aim of our study was to investigate selected pre-eclampsia (PE)-related miRNAs in clearly defined early- and late-onset PE (eoPE, loPE) cohorts and compare them with healthy controls.</p><h3>Methods</h3><p>This is a single-center, pilot study comparing pregnancies with eoPE (n=10) and loPE (n=8), each with separate healthy controls (n=10; n=8). Serum miRNA (miR-) expression levels of selected PE-associated miRNAs (miR-210-3p, miR-518b) were quantified by real-time PCR.</p><h3>Results</h3><p>Similar expression profiles (delta CT ± standard deviation) were observed between loPE vs. controls: miR-210-3p (8.20 ± 1 vs. 7.48 ± 1.2; p=0.16; Hodges-Lehmann estimator (HL): − 0.73, 95% confidence interval (CI) − 2.2 to 0.78) and miR-518b (9.82 ± 1.1 vs. 9.60 ± 0.9; p=0.80, HL: − 0.14, 95% CI − 1.61 to 0.91). Comparing eoPE cases to controls, we found an increase of miR-210-3p concentration (7.63 ± 1.1 vs. 9.31 ± 1.9; p=0.019; HL: 1.23, 95% CI 0.15 to 2.66, mean fold change: 3.2; sensitivity analysis: p=0.067) and a numerical difference in miR-518b expression without reaching statistical significance (8.77 ± 1.4 vs. 9.85 ± 1.8; p=0.19; HL: 0.70, 95% CI − 0.33 to 2.41; mean fold change: 2.1).</p><h3>Conclusion</h3><p>In the eoPE, miR-210-3p levels were higher than in controls, with the same trend observed in the sensitivity analysis, although statistical significance was no longer reached (p=0.067). miR-518b showed a numerical, non-significant difference between eoPE and controls. No significant differences were observed in loPE. Given the small sample size and overlap with early-onset fetal growth restriction, these findings should be considered exploratory.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13619671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}